Pharmaceutical machine companies are looking for new growth points, and diversified development has become the general trend!

[Pharmaceutical Network Market Analysis] Affected by favorable policies and expanding market demand, the development of the domestic pharmaceutical industry has begun to accelerate in recent years, and at the same time, the transformation and upgrading has continued to accelerat.
It is worth noting that, affected by this, the pharmaceutical equipment industry, which is a key link in the pharmaceutical production industry chain, has also ushered in a good opportunity for developmen.
While the market size is growing, it has started a new journe.
 Pharmaceutical machine companies are looking for new growth points, and diversified development has become the general trend! (Source: Pharmaceutical Network) Recently, Chutian Technology announced that the company intends to jointly fund the establishment of a company in Ningxiang City, Changsha, Hunan Province to provide medical equipment, medical equipment, mechanical engineering, et.
Precision manufacturing, mold, et.
as the main business of the compan.
The name of the joint venture company is Chutian Changxing Precision Manufacturing (Changsha) C.
, Lt.
("Chutian Changxing" "joint venture company"), with a registered capital of 50 million yua.
After the establishment of the company, Chutian Technology subscribed for 25 million yuan, accounting for 51% of its equity, and is a holding subsidiary of Chutian Technolog.
Industry analysts believe that this should be due to the fact that Chutian Technology is constantly promoting the diversification of its product structure in order to find more new growth point.
It is understood that Chutian Technology is a professional pharmaceutical equipment manufacturer in Chin.
It has been committed to providing professional and personalized pharmaceutical equipment solutions for pharmaceutical enterprise.
At present, its main products include freeze-dried preparation production overall solutions, water treatment systems, Ampoule bottle linkage line, vial linkage line, oral liquid linkage line, large infusion linkage line,et.
Driven by the industrialization needs of local biopharmaceutical innovation companies and the CDMO industry with global competitiveness, it has been increasing investment in R&D in recent years, accelerating technological transformation and product structure diversificatio.
It is reported that by introducing industry experts to form a team, Chutian Technology has been further improving the product line in the field of bioengineering, including stainless steel reactor, stock solution preparation, ultrafiltration chromatography purification, microsphere packing, SUT disposable technology products, et.
The solution competitiveness is expected to be further improve.
On the road of promoting diversified development, in fact, many companies have already begun to deplo.
As Canaan Technology mentioned on the interactive platform on August 5, in addition to the dominant position of oral solid preparation line equipment, the company's current business also covers powder processing equipment, traditional Chinese medicine extraction equipment, fluid processing equipment, intelligent logistics systems, pharmaceuticals The R&D consistency evaluation and testing services and other business sectors have formed a multi-field and diversified business layout mode.
The products and services are exported to more than 30 countries and regions around the worl.
Xinlai Yingcai has also been involved in the semiconductor industry since 201 After several years of layout and improvement of independent research and development capabilities, it has officially entered the high-clean vacuum and semiconductor market through the establishment of subsidiaries and the acquisition of GNB in ​​the United State.
At present, the company's main business is the research and development, production and sales of clean application materials and high-purity and ultra-high-purity application material.
The main products include high-clean vacuum chambers, pumps, valves, flanges, pipe fittings, pipes, et.
, involving application fields Including semiconductors, optoelectronics, photovoltaics, biomedicine, fine chemicals, food and beverages,et.
Judging from the company's 2021 annual report data, products in the food, pharmaceutical and pan-semiconductor fields contributed the main revenu.
In addition, Tofflon started with freeze dryers in the early year.
After years of diversified layout, it has also developed into an integrated supplier of pharmaceutical equipment, engineering and consumables in the field of pharmaceutical equipmen.
It can provide products ranging from pharmaceutical processes, core equipment consumables to Total solutions for systems engineerin.

It is worth mentioning that Tofflon is also setting up subsidiaries overseas through "acquisition + self-construction" and other methods to increase its international layout (Hong Kong, India, Indonesia, Turkey and Australia will be established in 2021.
is increasing year by yea.
In general, while many pharmaceutical equipment companies are accelerating their diversified development, they are also ushering in more new growth point.
The industry predicts that with the rapid development of the domestic innovative drug, biological drug industry and CDMO industry in the future, more and more domestic pharmaceutical equipment companies will accelerate their diversified layout and open up more and long-term growth spac.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyon.